Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6211-16-1
2. L-ornithine, Dihydrochloride
3. Ornithine Dihydrochloride
4. (s)-2,5-diaminopentanoic Acid Dihydrochloride
5. L-ornithine, Hydrochloride (1:2)
6. 8n284l2vlc
7. (2s)-2,5-diaminopentanoic Acid;dihydrochloride
8. Ornithine L-form Hcl
9. Unii-8n284l2vlc
10. Ornithine L-form Dihydrochloride
11. Einecs 228-277-5
12. Mfcd00066571
13. H-orn-oh.2hcl
14. (2s)-2,5-diaminopentanoic Acid Dihydrochloride
15. Schembl4813611
16. Dtxsid90884235
17. Akos015845479
18. Akos015961410
19. Ac-13805
20. As-66611
21. (s)-2,5-diaminovaleric Acid Dihydrochloride
22. Cs-0201664
23. O0089
24. L-ornithine Dihydrochloride, >=99.0% (at)
25. W-105048
26. Q27270772
| Molecular Weight | 205.08 g/mol |
|---|---|
| Molecular Formula | C5H14Cl2N2O2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 204.0432331 g/mol |
| Monoisotopic Mass | 204.0432331 g/mol |
| Topological Polar Surface Area | 89.3 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 95 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A L-Ornithine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Ornithine Dihydrochloride, including repackagers and relabelers. The FDA regulates L-Ornithine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Ornithine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A L-Ornithine Dihydrochloride supplier is an individual or a company that provides L-Ornithine Dihydrochloride active pharmaceutical ingredient (API) or L-Ornithine Dihydrochloride finished formulations upon request. The L-Ornithine Dihydrochloride suppliers may include L-Ornithine Dihydrochloride API manufacturers, exporters, distributors and traders.
L-Ornithine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Ornithine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Ornithine Dihydrochloride GMP manufacturer or L-Ornithine Dihydrochloride GMP API supplier for your needs.
A L-Ornithine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to L-Ornithine Dihydrochloride's compliance with L-Ornithine Dihydrochloride specifications and serves as a tool for batch-level quality control.
L-Ornithine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each L-Ornithine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Ornithine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Ornithine Dihydrochloride EP), L-Ornithine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Ornithine Dihydrochloride USP).
LOOKING FOR A SUPPLIER?
